Stock Analysis
Charlotte's Web Holdings Third Quarter 2024 Earnings: US$0.04 loss per share (vs US$0.099 loss in 3Q 2023)
Charlotte's Web Holdings (TSE:CWEB) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$12.6m (down 12% from 3Q 2023).
- Net loss: US$5.79m (loss narrowed by 62% from 3Q 2023).
- US$0.04 loss per share (improved from US$0.099 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Charlotte's Web Holdings Earnings Insights
Looking ahead, revenue is expected to decline by 4.0% p.a. on average during the next 3 years, while revenues in the Pharmaceuticals industry in Canada are expected to grow by 11%.
Performance of the Canadian Pharmaceuticals industry.
The company's shares are up 11% from a week ago.
Risk Analysis
Be aware that Charlotte's Web Holdings is showing 4 warning signs in our investment analysis and 1 of those is a bit unpleasant...
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSX:CWEB
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products.